Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc.（IOVA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
iova · 股价预测 · 20 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 20 位华尔街分析师
Buy
20 位分析师
共识
评级分布
12 个月目标价
High
$5.00
Consensus
$4.00
-3.0% upside
Low
$2.00
Median: $5 · Last Close: $4.13
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$4.00
-3.0% upside
High Target
$5
21.2%
Low Target
$2
-51.5%
Current Price
$4.13
as of today
Based on analyst price targets, the IOVA stock price prediction for the next 12 months ranges from $2 to $5. The consensus IOVA price forecast of $4.00 implies -3.0% upside from the current price of $4.13.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.30 | ↑ 4.31% |
1-day model range: $4.26–$4.35. Peak: $4.35 (+4.31%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -50.0% |
| 2028 | $2 | -63.8% |
| 2029 | $1 | -69.2% |
| 2030 | $1 | -71.8% |
| 2031 | — | -73.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IOVA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | Chardan Capital | Maintains | Buy→Buy |
| 2026-04-10 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-05 | UBS | Maintains | Neutral→Neutral |
| 2026-03-03 | Citizens | Upgrade ↑ | Market Perform→Market Outperform |
| 2026-02-25 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-25 | Citizens | Upgrade ↑ | Market Perform→Market Outperform |
| 2025-12-17 | Barclays | Maintains | Overweight→Overweight |
| 2025-11-24 | Barclays | Maintains | Overweight→Overweight |
| 2025-11-06 | Chardan Capital | Maintains | Buy→Buy |
| 2025-10-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Iovance Biotherapeutics, Inc. (IOVA) stock. Of the recent 150 rating actions, 9 were upgrades and 11 were downgrades. 20 analysts currently cover IOVA.
分析师推荐趋势
IOVA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$360M
↓ 50.0% YoY
Revenue Next Year
$494M
↑ 37.2% YoY
EPS This Year
$-0.55
EPS Next Year
$-0.31
↓ 43.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast IOVA EPS of $-0.55 for the current fiscal year, based on estimates from 6 analysts. The IOVA revenue forecast is $360M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IOVA 股价预测由两类独立数据源支撑：来自 20 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IOVA 的共识目标价为 $4.00（-3.0% 上行空间），分析师共识为 Buy。
IOVA 的短期预测（明日）为 $4.30（+4.31%）。 IOVA 对 2027 年的股价预测均值为 $2。 IOVA 对 2030 年的预测区间为 $1–$1。
Iovance Biotherapeutics, Inc. 在 NASDAQ 上市，代码 IOVA。IOVA 在 2027 年的整体展望偏积极，在覆盖分析师中约 75% 对应 Buy 共识。
常见问题
IOVA 预测 · 8 个问题根据 20 位华尔街分析师，IOVA 的 12 个月平均目标价为 $4.00，最高 $5.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $4.13，隐含约 -3.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.